A report by the European Alliance for Access to Safe Medicines (EAASM) has revealed that 60% of medicines sold by online pharmacies are fake or substandard.
According to IMS Health, sales of cancer drugs will grow at nearly double the rate of the global pharmaceutical market and could reach $80 billion by 2012.
In light of the British Medical Journal's controversial article asserting that pharma KOLs are no more than glorified sales reps, do you think there should be more transparency in industry's dealings with influential doctors?
Yes
60%
No
17%
This warrants further investigation first
24%
Thank you for voting
SUMMARY: A round-up of the latest news, events and insightful editorial on the theme of sales & marketing in the European pharmaceutical industry.